These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6093380)

  • 1. [Comparative analysis of immunoreactive indices in malignant and benign bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST
    Vopr Onkol; 1984; 30(10):19-25. PubMed ID: 6093380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of suppressor lymphocytes in the blood of oncological patients by using a 3-component lymphocyte mixed culture].
    Govallo VI
    Vopr Onkol; 1981; 27(9):30-6. PubMed ID: 6457445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymphocyte subpopulations in malignant bone tumors and their relation to the immune response to the tumor].
    Kosmiadi GA; Grigor'eva MP; Govallo VI
    Vopr Onkol; 1981; 27(2):43-7. PubMed ID: 6971012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decreased count of small lymphocytes in the blood of patients with malignant bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Efimtseva NN; Baranovskaia VT
    Vopr Onkol; 1987; 33(9):15-21. PubMed ID: 3499033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro immune response of patient lymphocytes to live autologous tumor cells].
    Grigor'eva MP; Kosmiadi GA; Govallo VI
    Vopr Onkol; 1980; 26(9):8-11. PubMed ID: 7423909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T-lymphocyte subsets in peripheral blood of patients with bone tumors].
    Guo W; Huang C
    Zhonghua Wai Ke Za Zhi; 1990 Apr; 28(4):235-7, 254. PubMed ID: 1974183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
    Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
    Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrophoretic mobility of T and B lymphocytes in bone tumor patients].
    Xie GL
    Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):39-41. PubMed ID: 3015533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary bone and joint tumor--statistical analysis of 571 cases].
    Yang DZ; Wu X
    Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):51-4. PubMed ID: 3015534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-immunological studies of 32 cases of bone tumors].
    Franchi F; Russo V; Luzi G; Santori FS; De Chiara N; Aiuti F
    Minerva Med; 1980 Jun; 71(25):1815-22. PubMed ID: 6968049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological study in carcinogenesis. Distribution of tissue incompatibility antigens (system HL-A) in oncological patients].
    Govallo VI; Shelepina TA
    Vopr Onkol; 1975; 21(9):13-9. PubMed ID: 1059274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma.
    Byers VS; Levin AS; Johnston JO; Hackett AJ
    Cancer Res; 1975 Sep; 35(9):2520-31. PubMed ID: 1097109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
    Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
    No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative analysis of immune response indices in lung cancer].
    Govallo VI; Dubrovskiĭ AV; Grigor'eva MP; Kosmiadi GA; Efimtseva NN
    Vopr Onkol; 1985; 31(1):39-44. PubMed ID: 3156450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Benign tumors of the bone].
    Cornu JC; Livio JJ; Saegesser F
    Helv Chir Acta; 1973 Mar; 40(1):91-105. PubMed ID: 4700091
    [No Abstract]   [Full Text] [Related]  

  • 16. [Osteoplasty in the treatment of benign tumors and tumor-like formations of the bones].
    Knysh IT
    Vestn Khir Im I I Grek; 1974 Dec; 113(12):76-9. PubMed ID: 4446261
    [No Abstract]   [Full Text] [Related]  

  • 17. [Selected immunologic indicators in malignant bone tumors].
    Keleová A; Huraj E; Jahnová E; Janota S; Nyulassy S
    Acta Chir Orthop Traumatol Cech; 1990 Feb; 57(1):77-88. PubMed ID: 2336911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indices of cellular and humoral immunity following surgery intervention for malignant bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST; Makhson NE
    Vopr Onkol; 1976; 22(1):7-13. PubMed ID: 1083589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone plasty in the treatment of benign bone neoplasms and certain precancerous conditions].
    Stamatin SI; Marin IM; Vukolova VV
    Ortop Travmatol Protez; 1974 Oct; 0(10):25-9. PubMed ID: 4610467
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.